• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of October 17, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2157-12
Classification Class II
Code Info 4180357508, 4180356223, 4180355586, 4180354295, 4180353710, 4180352509, 4180351968, 4180350287, 4180349041, 4180348511, 4180347274, 4180345499, 4180344657, 4180343823, 4180343000, 4180341053, 4180340360, 4180337642, 4180336133, 4180335468, 4180334421, 4180333841, 4180332742, 4180332015, 4180330994, 4180330361, 4180328295, 4180326367, 4180324587, 4180318627, 4180317614, 4180316239, 4180315098, 4180313340, 4180311686, 4180309998, 4180307699, 4180306098, 4180304902, 4180304275, 4180303246, 4180299690, 4180299081, 4180296193, 4180295467, 4180294037, 4180293389, 4180292056
Product Distributed Qty 48 units
Reason For Recall Blood products, collected from a donor whose routine physical examination was inadequately documented, were distributed.

Event Detail

Event Id 51349
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc
City Charlotte
State NC
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2009-01-09
Initial Firm Notification of Consignee or Public Other
Distribution Pattern IL & Switzerland
-
-